STOCK TITAN

Lazard Ltd Stock Price, News & Analysis

LAZ NYSE

Welcome to our dedicated page for Lazard news (Ticker: LAZ), a resource for investors and traders seeking the latest updates and insights on Lazard stock.

Lazard Ltd (LAZ) maintains its position as a global leader in financial advisory and asset management through strategic insights and operational excellence. This dedicated news hub provides investors with essential updates on corporate developments, market strategies, and financial performance.

Access authoritative reports on mergers & acquisitions, quarterly earnings disclosures, leadership changes, and regulatory filings. Our curated collection simplifies tracking LAZ's advisory engagements in restructuring and capital markets while monitoring its asset management division's international equity strategies.

Key updates include detailed analyses of cross-border transactions, institutional client partnerships, and operational expansions across 27 countries. Professionals rely on this resource for timely insights into LAZ's advisory role in complex corporate finance matters and its evolving position in global capital markets.

Bookmark this page for structured access to press releases and expert commentary. Regular updates ensure you remain informed about LAZ's strategic direction and industry impact without promotional bias.

Rhea-AI Summary

Lazard Ltd (NYSE: LAZ) has appointed Spyros Svoronos as Managing Director and Global Head of Chemicals within its Financial Advisory business. This appointment is effective immediately and follows Svoronos' tenure at Credit Suisse, where he led the Global Industrials Group and served as Global Head of Chemicals. Richard Whitney, previously the Global Head of Chemicals, will transition to Vice Chairman of Investment Banking. This strategic move enhances Lazard’s advisory capabilities in the chemicals sector.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1%
Tags
none
-
Rhea-AI Summary

William M. Lewis, Jr. has joined Lazard's Board of Directors as of April 29, 2022, while announcing his retirement from the firm on November 12, 2022. Lewis has served as a Managing Director for 17 years, most recently as Chairman of Investment Banking. He will transition to Apollo Global Management as a Senior Partner on November 15. Kenneth M. Jacobs, CEO of Lazard, praised Lewis as an influential investment banker and advisor to high-profile CEOs.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.18%
Tags
management
-
Rhea-AI Summary

Lazard Ltd (NYSE: LAZ) reported preliminary assets under management (AUM) of approximately $272.6 billion as of September 30, 2021. This figure includes $6.3 billion in market depreciation, $2.6 billion in foreign exchange depreciation, and $1.3 billion in net outflows. The average AUM for the quarter was $277.9 billion. In comparison, AUM was $282.8 billion at the end of August 2021.

The report highlights a decline in AUM owing to various market factors and outflows.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.18%
Tags
none
Rhea-AI Summary

Lazard Ltd (NYSE: LAZ) has announced the recruitment of Andrew Sweet as a Managing Director in their Charlotte office, focusing on the Industrials Group. Sweet, who has over 15 years of experience in M&A, private capital raising, and public financing, previously held positions at Stephens, Inc. and Hyde Park Capital. The firm, which operates in 41 cities worldwide, continues to enhance its advisory services to clients across various sectors.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.57%
Tags
none
-
Rhea-AI Summary

Lazard Ltd (NYSE: LAZ) has appointed Medha Chadha and Jason Schoenholtz as Managing Directors in Financial Advisory, focusing on healthcare clients. Ms. Chadha will lead capital markets advisory, leveraging 16 years of equity capital markets experience, particularly in biotech. Mr. Schoenholtz, with nearly two decades in healthcare investment banking, will enhance the team's expertise in healthcare services. This strategic expansion aims to improve Lazard’s advisory capabilities in the healthcare sector.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.83%
Tags
none
-
Rhea-AI Summary

Lazard Ltd (NYSE: LAZ) released its annual study on challenges and opportunities in the global healthcare sector, surveying 200 executives and investors. The report indicates that the majority expect the COVID-19 pandemic to persist through 2022 and beyond, raising concerns about vaccine hesitancy and new variants. Key findings include a permanent shift to digital healthcare, ongoing strategic M&A activity, and pricing challenges. The study reflects healthcare leaders' views on innovation and the implications of the pandemic, with expectations for increased virtual healthcare delivery and a focus on scientific advancement.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.4%
Tags
none
Rhea-AI Summary

The Board of Directors of Lazard Global Total Return and Income Fund (NYSE:LGI) has declared a monthly distribution of $0.11512 per share on its outstanding common stock. This distribution will be payable on October 22, 2021, to shareholders of record as of October 8, 2021. The ex-dividend date is set for October 7, 2021. The Fund's investment strategy focuses on total return through capital appreciation and income, investing in a diverse portfolio of US and non-US equities, including companies with market caps over $2 billion, and may also include emerging market investments.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.18%
Tags
none
-
Rhea-AI Summary

Lazard Ltd (NYSE: LAZ) reported its preliminary assets under management (AUM) as of August 31, 2021, totaling approximately $282.8 billion. This figure included market appreciation of $5.0 billion and foreign exchange depreciation of $0.5 billion, alongside net outflows of $17 million. AUM composition showed equity at $228.8 billion, fixed income at $48.2 billion, and other investments at $5.8 billion.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.1%
Tags
none
-
Rhea-AI Summary

Lazard Ltd (NYSE: LAZ) has appointed Simon Auerbach as Managing Director and Co-Head of Information Services in Financial Advisory’s Telecom, Media and Entertainment (TME) group, effective immediately. He will work alongside Richard Hoyle in New York. Auerbach brings extensive experience from Credit Suisse, Foros, and Goldman Sachs. His addition aims to enhance Lazard's TME capabilities, as stated by Garrett Baker, Global Co-Head of TME, who highlighted Auerbach's leadership in mergers and acquisitions within the sector.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.52%
Tags
none
Rhea-AI Summary

Lazard Ltd (NYSE:LAZ) has appointed Patrick No as Managing Director in the Private Capital Advisory Group, effective immediately. Based in Singapore, No will focus on fundraising and secondary solutions in the Asia Pacific region. He brings extensive experience from Credit Suisse and J.P. Morgan, enhancing Lazard's advisory capabilities in this key market.

Holcombe Green, Global Head of Private Capital Advisory, highlighted that No's addition strengthens the team's expertise and supports the firm's growth strategy in APAC.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.48%
Tags
none

FAQ

What is the current stock price of Lazard (LAZ)?

The current stock price of Lazard (LAZ) is $51.92 as of July 11, 2025.

What is the market cap of Lazard (LAZ)?

The market cap of Lazard (LAZ) is approximately 4.7B.
Lazard Ltd

NYSE:LAZ

LAZ Rankings

LAZ Stock Data

4.74B
91.69M
2.79%
72.83%
7.16%
Capital Markets
Investment Advice
Link
United States
NEW YORK